Search

Learn about the MSK Healthy Living program that provides breast cancer patients with a custom plan tailored to their needs to help with nutrition and exercise, integrative medicine; support for mental, emotional, and spiritual well-being and much more.

… Thursday, September 28, 2023 Marcia McFayden, a retired elementary school computer teacher, came to Memorial Sloan Kettering Cancer Center (MSK) determined to recover her health when she was diagnosed with stage 1 breast cancer . During her successful treatment, Marcia also set a new goal for herself

Learn how to make guests with cancer feel welcome and included at the table this holiday season.

… Monday, November 22, 2021 Holidays are all about traditions, and food is at the center of many of them. For people with cancer, though, hearty holiday foods may be hard to enjoy because cancer treatments can sometimes cause poor appetite , nausea , and additional side effects. But holiday hosts can stay

The July 27 MSK Science Spotlight features Immunology Program Chair and Director of the Ludwig Center for Cancer Immunotherapy at MSK, Alexander Rudensky, PhD.

… Monday, July 27, 2020 The July 27 MSK Science Spotlight features Immunology Program Chair and Director of the Ludwig Center for Cancer Immunotherapy at MSK, Alexander Rudensky, PhD . He will be presenting, “A Cell-Extrinsic Mechanism Limiting Immunity and Inflammation.” Dr. Rudensky is an internationally

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

… Monday, June 15, 2020 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Design and Construction of David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center Recognized by Industry Leaders David H. Koch Center for Cancer Care at Memorial

Researchers are developing uses for a drug that could benefit many people with lung cancer.

… Tuesday, March 15, 2016 Summary Although some lung cancer patients have benefited from developments in precision therapy, those with mutations in a gene called KRAS have not. Now MSK researchers are developing uses for a compound that targets a common KRAS mutation in lung cancer. Highlights KRAS has

Go behind the scenes with Filemon Dela Cruz, who cares for children with sarcoma and conducts precision medicine research at Memorial Sloan Kettering.

… Monday, September 17, 2018 Summary Precision oncology is based on the idea that people can be treated according to the genetic changes that cause a tumor to grow and spread. At Memorial Sloan Kettering, this area of medicine is helping both children and adults. Here, pediatric sarcoma specialist Filemon

Researchers have found the first evidence that susceptibility to developing acute lymphoblastic leukemia during childhood may be heritable.

… Monday, September 9, 2013 Summary Researchers have found the first evidence that susceptibility to developing acute lymphoblastic leukemia during childhood may be heritable. A new international study led by physicians and scientists from Memorial Sloan Kettering has discovered a gene mutation linked

A new MSK study finds that in colorectal cancer, not all regulatory T cells are created equal. One subtype suppresses cancer growth while another aids it. The findings could help improve immunotherapy treatment for the majority of patients with colorectal cancer, and potentially for other cancers.

… Monday, December 15, 2025 In most solid tumors, high numbers of regulatory T (Treg) cells are associated with poorer outcomes because they dampen the immune system’s ability to fight against a tumor. Colorectal cancer, however, is a puzzling exception. A high density of Treg cells in colorectal tumors

Advances in diagnosis and treatment, especially those made over the past ten years, have played a significant role in the decline in cancer deaths. Learn about those advances — and what to expect in the next ten years.

… Tuesday, February 4, 2020 Summary Larry Norton, Senior Vice President at Memorial Sloan Kettering, discusses some of the biggest achievements in cancer care made between 2010 and 2019, and what he hopes to see next. In January, the American Cancer Society reported that the rate of cancer deaths in the

Read about MSK research that sheds light on how the innate immune system interacts with developing cancer cells.

… Monday, October 6, 2025 Understanding the interaction between immune cells and cancer cells has important implications for  cancer immunotherapies , including  checkpoint inhibitor drugs and cell-based therapies, as well as newer treatments like  cancer vaccines . Over the last decade,  computational